Medela LLC reported on Tuesday the receipt of a group purchasing contract for its Lactation Care, including breast pumps, from Vizient Inc, health care company.
Headquartered in Switzerland, Medela will provide research-based breast milk feeding solutions to support a mother's ability to provide the life-giving benefits of breast milk to her baby.
This agreement is in addition to Vizient prior contracts for Medela's full product portfolio from their Human Milk business unit, including enteral feeding and accessories.
Vizient's diverse membership base includes academic medical centres, paediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume.
Founded in 1961, Medela concentrates on two business units: Human Milk, which provides research-based breast milk feeding solutions as well as Healthcare, which is based on the engineering and manufacturing medical vacuum technology solutions.
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study
Precision Epigenomics partners with TruDiagnostic
Modalis partners with Ginkgo Bioworks
Stamford Pharmaceuticals starts locally advanced basal cell carcinoma (laBCC) trial of SP-002
Algiax Pharmaceuticals reveals update on chronic neuropathic pain study